Article
C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
PLoS pathogens - 1 Dec 2009
Lecordier Laurence, Vanhollebeke Benoit, Poelvoorde Philippe, Tebabi Patricia, Paturiaux-Hanocq Françoise, Andris Fabienne, Lins Laurence, Pays Etienne
Abstract excerpt
Apolipoprotein L-I (apoL1) is a human-specific serum protein that kills Trypanosoma brucei through ionic pore formation in endosomal membranes of the parasite. The T. brucei subspecies rhodesiense and gambiense resist this lytic activity and can infect humans, causing sleeping sickness. In the case of T. b. rhodesiense, resistance to lysis involves interaction of the Serum Resistance-Associated (SRA) protein with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
